Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK101 in Knee Osteoarthritis
NCT04858659Phase 3Unknown
- Sponsor
- PMG Pharma
- Start
- May 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of PG201 in knee osteoarthritis (OA), sponsored by PMG Pharma. Status: unknown.
02
Drugs
PG201
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04858659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04858659.